Correlation Between Transcode Therapeutics and Paltalk
Can any of the company-specific risk be diversified away by investing in both Transcode Therapeutics and Paltalk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Transcode Therapeutics and Paltalk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Transcode Therapeutics and Paltalk, you can compare the effects of market volatilities on Transcode Therapeutics and Paltalk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Transcode Therapeutics with a short position of Paltalk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Transcode Therapeutics and Paltalk.
Diversification Opportunities for Transcode Therapeutics and Paltalk
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Transcode and Paltalk is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Transcode Therapeutics and Paltalk in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Paltalk and Transcode Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Transcode Therapeutics are associated (or correlated) with Paltalk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Paltalk has no effect on the direction of Transcode Therapeutics i.e., Transcode Therapeutics and Paltalk go up and down completely randomly.
Pair Corralation between Transcode Therapeutics and Paltalk
Given the investment horizon of 90 days Transcode Therapeutics is expected to under-perform the Paltalk. In addition to that, Transcode Therapeutics is 2.97 times more volatile than Paltalk. It trades about -0.01 of its total potential returns per unit of risk. Paltalk is currently generating about 0.04 per unit of volatility. If you would invest 150.00 in Paltalk on August 24, 2024 and sell it today you would earn a total of 31.00 from holding Paltalk or generate 20.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Transcode Therapeutics vs. Paltalk
Performance |
| Timeline |
| Transcode Therapeutics |
| Paltalk |
Transcode Therapeutics and Paltalk Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Transcode Therapeutics and Paltalk
The main advantage of trading using opposite Transcode Therapeutics and Paltalk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Transcode Therapeutics position performs unexpectedly, Paltalk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Paltalk will offset losses from the drop in Paltalk's long position.| Transcode Therapeutics vs. Xenetic Biosciences | Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings | Transcode Therapeutics vs. Eyenovia | Transcode Therapeutics vs. Cognition Therapeutics |
| Paltalk vs. Sphere 3D Corp | Paltalk vs. Society Pass | Paltalk vs. Marin Software | Paltalk vs. EzFill Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |